Diagnosis

If your child has a history of bleeding—especially joint bleeding—or excessive bruising, your doctor may suspect a bleeding disorder. Simple blood tests are the standard for diagnosing a child with hemophilia. The tests will check the level of factor VIII and factor IX in the child’s blood. If the tests show an insufficient amount of factor VIII, the diagnosis will be hemophilia A, the most common type of hemophilia. An insufficient amount of factor IX means a diagnosis of hemophilia B. Depending on how low the levels of factor VIII or factor IX, the child’s hemophilia will be classified as mild, moderate, or severe.

Learn about treatment options for hemophilia.

Helixatefs.com

Important Safety Information for Helixate^®FS

Helixate^® FS is a recombinant factor VIII (FVIII) product used to treat hemophilia A when there is a demonstrated deficiency of FVIII, a plasma clotting factor.

Helixate^® FS should be administered cautiously in patients with previous hypersensitivity to constituents of FVIII preparations of known sensitivity to mouse or hamster protein.

Adverse events are generally minor. The most common adverse events include injection-site reactions, dizziness, and rash.

For more information about Helixate^® FS, please see full Prescribing Information.